Stevens Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Stevens Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-21,744	Closed	-$96K	–	1155
2016 Q4	$96K	Sell	21,744 -4,299	-17%	-$18K	﹤0.01%	820
2016 Q3	$122K	Sell	26,043 -11,630	-31%	-$68.9K	0.01%	842
2016 Q2	$248K	Buy	+37,673	New	+$266K	0.01%	725
2015 Q4	–	Sell	-60,410	Closed	-$361K	–	1202
2015 Q3	$361K	Buy	60,410 +25,948	+75%	+$180K	0.02%	639
2015 Q2	$236K	Buy	34,462 +15,568	+82%	+$98.8K	0.01%	821
2015 Q1	$115K	Sell	18,894 -70,608	-79%	-$470K	﹤0.01%	914
2014 Q4	$620K	Buy	+89,502	New	+$658K	0.02%	529
2013 Q3	–	Sell	-16,514	Closed	-$123K	–	1251
2013 Q2	$123K	Buy	+16,514	New	+$127K	﹤0.01%	854

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Stevens Capital Management's SPPI Position: Q1 2017 in Review

Stevens Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2017, closing a stake of 21,744 shares — an estimated $96K sold.

Stevens Capital Management first reported a position in SPPI in Q2 2013 and held it in 8 quarters. The position peaked at $620K in Q4 2014. 128 funds tracked by Wall St. Rank hold SPPI as of Q1 2017.

Stevens Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Stevens Capital Management sold 21,744 Spectrum Pharmaceuticals Inc shares in Q1 2017, an estimated $96K.
Stevens Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 8 quarters.
Stevens Capital Management's Spectrum Pharmaceuticals Inc position peaked at $620K in Q4 2014.
128 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2017.

Based on Stevens Capital Management's 13F filing for Q1 2017, filed 8 May 2017.